Home › Drug Codes › J Codes › J9036 · BELRAPZO
Updated July 1st, 2026

BELRAPZO J Code: J9036

Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9036, effective October 1, 2026: $9.264 per HCPCS billing unit, down 20.1% from $11.599. From CMS's final file.

?
Medicare Payment Limit ?
$11.599
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$11.599
/ HCPCS billing unit · APC 9313
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
3
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
HCPCS Added Date July 1, 2019
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Multi-Dose
Dosage Form Injection | Injection, Solution

About BELRAPZO

Belrapzo is a medication aligned to the HCPCS J Code: J9036 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used to treat certain types of cancer. Bendamustine belongs to a class of cancer chemotherapy drugs known as alkylating agents. It works by killing cancer cells or slowing their growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
10019-0079-01 Bendamustine Hydrochloride Baxter Healthcare Corporation 100 100 MG
42367-0521-25 Belrapzo Eagle Pharmaceuticals, Inc 100 100 MG / 4 ML
60505-6228-00 Bendamustine Hydrochloride Apotex Corp 100 125 MG / 5 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

BELRAPZO Pricing & Reimbursement

J9036 Private Payer Reimbursement
$13.90 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Bendamustine Hydrochloride 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J9033 Generic Code (Multiple Manufacturers) Bendamustine Hydrochloride Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
J9034 Teva Bendamustine Hydrochloride Injection, bendamustine hcl (bendeka), 1 mg
J9036 Generic Code (Multiple Manufacturers) Bendamustine Hydrochloride Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
J9056 Generic Code (Multiple Manufacturers) Bendamustine Hydrochloride Injection, bendamustine hydrochloride (vivimusta), 1 mg

BELRAPZO Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 12.84%
Avg. Days to File 9.4days
Avg. Days to Pay 25.5days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9036 claims analytics on FocalPoint →
OnPoint Oncology

BELRAPZO CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Belrapzo (J9036) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9036. Wastage billing guide →

BELRAPZO Medically Unlikely Edits (MUE)

The most billing units of J9036 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
360 units / day
= 360 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

BELRAPZO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma indolent B-cell non-Hodgkin lymphoma
Drug Class
Alkylating Activity [MoA]Alkylating Drug [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Belrapzo billing and coding guide?
Billing and coding information for BELRAPZO can be found through Eagle Pharmaceuticals. Visit Here →
Are there any available Belrapzo patient assistance programs?
BELRAPZO patient assistance information can be found through Eagle Pharmaceuticals. Visit Here →
Where can I find Belrapzo prescribing information?
BELRAPZO prescribing information can be found at the link below: Visit Here →
Where can I find Belrapzo side effect information?
Information regarding BELRAPZO's side effects can be found at MedlinePlus Visit Here →
Does billing BELRAPZO require JZ/JW wastage modifiers?
CMS does not include BELRAPZO (J9036) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9036. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to BELRAPZO.

J9033TREANDAInjection, bendamustine hydrochloride, not otherwise specified, 1 mgMultiple ManufacturersAdded January 1, 2009J9034BENDEKAInjection, bendamustine hcl (bendeka), 1 mgTevaAdded January 1, 2017J9056VIVIMUSTAInjection, bendamustine hydrochloride (vivimusta), 1 mgAzurity Pharmaceuticals IncAdded July 1, 2023J9058BENDAMUSTINE (APOTEX)Injection, bendamustine hydrochloride (apotex), 1 mgApotexAdded July 1, 2023J9059BENDAMUSTINE HYDROCHLORIDEInjection, bendamustine hydrochloride (baxter), 1 mgBaxter HealthcareAdded July 1, 2023J9000ADRIAMYCINInjection, doxorubicin hydrochloride, 10 mgMultiple ManufacturersAdded January 1, 1984J9071CyclophosphamideInjection, cyclophosphamide (auromedics), 5 mgEugia USAdded April 1, 2022J9072CYCLOPHOSPHAMIDE (AVYXA)Injection, cyclophosphamide (frindovyx), 5 mgAvyxa PharmaAdded January 1, 2024J9260METHOTREXATEInjection, methotrexate sodium, 50 mgMultiple ManufacturersAdded January 1, 1984J9301GAZYVAInjection, obinutuzumab, 10 mgGenentechAdded January 1, 2015